Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Ordinary Shares, $0.0005 par value
-
Shares outstanding
-
25.1M
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
292K
-
Shares change
-
+237K
-
Total reported value, excl. options
-
$433K
-
Value change
-
+$351K
-
Number of buys
-
6
-
Price
-
$1.48
Significant Holders of Meihua International Medical Technologies Co., Ltd. - Ordinary Shares, $0.0005 par value (MHUA) as of Q4 2023
8 filings reported holding MHUA - Meihua International Medical Technologies Co., Ltd. - Ordinary Shares, $0.0005 par value as of Q4 2023.
Meihua International Medical Technologies Co., Ltd. - Ordinary Shares, $0.0005 par value (MHUA) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 292K shares
of 25.1M outstanding shares and own 1.16% of the company stock.
Largest 8 shareholders include MARSHALL WACE, LLP (148K shares), RENAISSANCE TECHNOLOGIES LLC (71K shares), CITADEL ADVISORS LLC (39.6K shares), GEODE CAPITAL MANAGEMENT, LLC (16.8K shares), Virtu Financial LLC (14.6K shares), MORGAN STANLEY (2.79K shares), UBS Group AG (151 shares), and Tower Research Capital LLC (TRC) (16 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.